CURRENT MEDICAL AND DRUG RESEARCH

Articles>> Volume 5 Issue 1, 2021

CURRENT MEDICAL AND DRUG RESEARCH
Elucidation of the origin of autoimmune diseases via computational multiscale mechanobiology and extracellular matrix remodeling: theories and phenomenon of immunodominance
Rajiv Kumar
Curr Med Drug Res 5 (1): Art. ID 215 (2021)
Experimental practices of computational multiscale mechanobiology were applied to explicate different topographies of mechanobiology and to predict the fine minutiae of mechanosensing and mechanotransduction in a cellular system accurately. Autoimmune diseases denoted as biologically implausible. Recently, scientific and medical communities investigated autoimmune diseases and associated settings to conclude the disarrays of autoimmune as earlier as possible. Therefore, an urgent need is there to evaluate ocular immunology and the route of growth of autoimmune diseases. Scientific investigations play a significant role to detect interrelated cures and bearing research for probing treatments for autoimmune diseases, which are yet undiscovered. Extracellular matrix remodeling followed in the cellular microenvironment dynamically to manage remodelling events. Immunodominance deals with the immunodominance mechanism evolved in response to clearing any type of infection and not yet distinguished entirely.

Related Article

COVID-19 and risk of cardiomyocyte injury: The prevailing scenario
Marwa S. Al-Niemi, Nawar R. Hussain, Hayder M. Al-Kuraishy and Ali I. Al-Gareeb2
Curr Med Drug Res 5 (1): Art. ID 211 (2021)

The potential role of Bromhexine in the management of COVID-19: Decipher and a real game-changer
Hayder M. Al-Kuraishy, Marwa S. Al-Niemi, Nawar R. Hussain, Ali I. Al-Gareeb and Claire Lugnier
Curr Med Drug Res 5 (1): Art. ID 212 (2021)

Current and future role of immobilized enzymes in medical field
Mohammad Rafiq Khan
Curr Med Drug Res 5 (1): Art. ID 213 (2021)

Spatial mapping and enshrined capacity: Assessment of COVID-19 servicing Indian hospitals
N. Ravichandran, S. Shivangi and B. Rakesh
Curr Med Drug Res 5 (1): Art. ID 214 (2021)